It is a healthcare public limited company based in Mumbai, Maharashtra, India, established in 2019.
2019 | Mumbai, Maharashtra, India | Struck OffSpeciality Therapeutics Limited, a struck off public limited company, was established on 06 May 2019 in Mumbai, Maharashtra, India. Engaging in medical & laboratory equipment within the healthcare sector, it holds CIN: U33309MH2019PLC324955. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.70 K .
Its leadership includes Hoshmand Jal Bamji (Director), Jayshree Ramasubramanian (Director), Alok Dayanand Sureka (Additional Director). Past directors included Dibakar Satyabrata Chatterjee, Bhushan Sharad Punekar, Hoshmand Jal Bamji. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at 47 A To Z Industrial Estate, Ganpatrao Kadam Marg, Lower Parel (W),, Mumbai, Maharashtra, 400013.
U33309MH2019PLC324955
324955
06 May 2019
₹0.50 M
₹0.70 K
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Speciality Therapeutics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hoshmand Jal Bamji | Director | 07 Nov 2019 | Current |
| Jayshree Ramasubramanian | Director | 06 May 2019 | Current |
| Alok Dayanand Sureka | Additional Director | 23 Feb 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Dec 2019 | Past |
| Pramod Abcsdd | Director | 23 Feb 2022 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Speciality Therapeutics Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Speciality Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Speciality Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Speciality Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Speciality Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Alok Dayanand Sureka was appointed as a Additional Director was appointed as a Additional Director on 23 Feb 2022 & has been associated with this company since 3 years 10 months . was completed.
Progress on Speciality Therapeutics Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was documented.
Progress on Speciality Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was documented.
The activity Hoshmand Jal Bamji was appointed as a Director was appointed as a Director on 07 Nov 2019 & has been associated with this company since 6 years 1 month . was completed.
Jayshree Ramasubramanian was appointed as a Director was appointed as a Director on 06 May 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.
Progress on Speciality Therapeutics Limited was registered on 06 May 2019 with Roc Mumbai & aged 6 years 7 months as per MCA records. was documented.
The CIN of Speciality Therapeutics Limited is U33309MH2019PLC324955.
Speciality Therapeutics Limited is headquartered at 47 A To Z Industrial Estate, Ganpatrao Kadam Marg, Lower Parel (W),, Mumbai, Maharashtra, 400013.
Speciality Therapeutics Limited was incorporated on 06 May 2019.
The current directors of Speciality Therapeutics Limited are
The primary industry of Speciality Therapeutics Limited is Healthcare.
Speciality Therapeutics Limited is unlisted.
The authorized capital of Speciality Therapeutics Limited is ₹0.50 M, and the paid-up capital is ₹0.70 K .
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX